Screener
Alto Neuroscience ANRO Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Alto Neuroscience in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The source filing: Alto Neuroscience’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 7:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001999480-26-000012
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Accrued payroll, vacation and employee-related expenses | $2,001 | $4,870 |
| Accrued research | 3,142 | 2,124 |
| Accrued interest, short term | 115 | 118 |
| Other accruals and current liabilities | 1,048 | 599 |
| Lease liability, short term | 1,304 | 1,151 |
| Total accrued expenses and other current liabilities | $7,610 | $8,862 |
Item 1. Financial Statements (Unaudited).
FAQ
- What is Alto Neuroscience's operating lease liabilities (current)?
- Alto Neuroscience (ANRO) reported operating lease liabilities (current) of $1.3M in Q1 2026.
- How has Alto Neuroscience's operating lease liabilities (current) changed year-over-year?
- Alto Neuroscience's operating lease liabilities (current) increased by 48.9% year-over-year, from $876K to $1.3M.
- What is the long-term trend for Alto Neuroscience's operating lease liabilities (current)?
- Over 2 years (2023 to 2025), Alto Neuroscience's operating lease liabilities (current) has grown at a 203.4% compound annual growth rate (CAGR), from $125K to $1.15M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.
Ask your AI about Alto Neuroscience's operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude